GPT and Hepatic failure: The levels of ALT, AST, and TBIL and the MELD score at all postbaseline time points were significantly lower than those at baseline in the liver failure group, and the value of PTA gradually increased after UCMSC treatment in the liver failure group (Fig. 1).